Literature DB >> 33080399

Inflow cannula obstruction of the HeartWare left ventricular assist device: what do we really know?

Federico Pappalardo1, Letizia F Bertoldi2, Francesca Sanvito3, Claudia Marini4, Filippo Consolo5.   

Abstract

In the setting of HeartWare left ventricular assist device (HVAD, Medtronic) implantation, pre-pump blood flow obstruction has been described due to intraventricular thrombus formation occluding the inflow cannula. This phenomenon often evolves in suboptimal pump performance, and requires prompt management to prevent its progression. However, to date, effective strategies and tools for the diagnosis and management of this complication are poorly described. We report a case of HVAD inflow cannula obstruction that drove later in-pump thrombosis and, eventually, complete cannula occlusion, and discuss gap of knowledge and limitations of currently available diagnostic and therapeutic tools in this scenario. Furthermore, we reinforce the value of time-frequency analysis of the HVAD log files to early identify abnormal pump operation associated with inflow cannula obstruction despite unremarkable trends of pump parameters.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  HeartWare HVAD; Inflow cannula obstruction; Left ventricular assist device; Log files; Thrombosis

Mesh:

Year:  2020        PMID: 33080399     DOI: 10.1016/j.carpath.2020.107299

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  2 in total

1.  Influence of shear rate and surface chemistry on thrombus formation in micro-crevice.

Authors:  Mansur Zhussupbekov; Wei-Tao Wu; Megan A Jamiolkowski; Mehrdad Massoudi; James F Antaki
Journal:  J Biomech       Date:  2021-03-26       Impact factor: 2.789

2.  Real-Time Analysis of the Log Files of the HeartWare Continuous-Flow Left Ventricular Assist Device for the Early Diagnosis of Pump Thrombosis: a Step Forward Toward Clinical Translation.

Authors:  Filippo Consolo; Federico Pappalardo
Journal:  J Cardiovasc Transl Res       Date:  2021-07-19       Impact factor: 3.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.